在相互易位植入前遗传学诊断周期中优先选择并移植整倍体非携带者胚胎
本研究开发并验证一种新策略,用于在相互易位植入前遗传学诊断(PGD)周期中区分平衡/整倍体携带者与非携带者胚胎,并成功在选择性移植非携带者胚胎后获得活产。研究采用回顾性与前瞻性设计,对11例患者进行配对测序以确定易位断点,随后进行临床PGD周期。结果显示,82%(9/11)的患者成功确定易位断点,并在前瞻性周期中通过移植非携带者胚胎获得正常核型活产。
要点
- 配对测序联合PCR断点分析可区分平衡/整倍体胚胎的携带者状态。
- 在11例患者中,9例(82%)成功确定了易位断点。
- 前瞻性移植非携带者胚胎后获得健康女婴,核型正常。
核心结论
- 配对测序联合PCR断点分析是一种新颖、可靠且准确的策略,可区分平衡/整倍体胚胎中的携带者与非携带者。
- 该方法在相互易位或其他结构重排患者的临床PGD周期中具有潜在应用价值。
研究设计与样本
- 回顾性与前瞻性研究,在体外受精(IVF)单位进行。
- 共纳入11例患者,先进行配对测序以确定易位断点,随后进行临床PGD周期。
- 干预措施为胚胎活检联合24条染色体检测,以确定平衡/整倍体胚胎的携带者状态。
主要发现
- 在11例患者中,9例(82%)成功确定了易位断点。
- 在4例已通过未知携带者状态的平衡/整倍体胚胎建立足月PGD妊娠的患者中,回顾性确定了正确的携带者状态,并与新生儿的细胞遗传学核型匹配。
- 在一例46,XY,t(7;14)(q22;q24.3)易位患者的前瞻性PGD周期中,鉴定出4个平衡/整倍体胚胎,包括3个携带者和1个非携带者。
- 移植非携带者胚胎后,分娩一健康女婴,随后确认核型为正常46,XX。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop and validate a new strategy to distinguish between balanced/euploid carrier and noncarrier embryos in preimplantation genetic diagnosis (PGD) cycles for reciprocal translocations and to successfully achieve a live birth after selective transfer of a noncarrier embryo. DESIGN: Retrospective and prospective study. SETTING: In vitro fertilization (IVF) units. PATIENT(S): Eleven patients undergoing mate pair sequencing for identification of translocation breakpoints, followed by clinical PGD cycles. INTERVENTION(S): Embryo biopsy with 24-chromosome testing to determine carrier status of balanced/euploid embryos. MAIN OUTCOME MEASURE(S): Definition of translocation breakpoints and polymerase chain reaction (PCR) diagnostic primers, correct diagnosis of euploid embryos for carrier status, and a live birth with a normal karyotype after transfer of a noncarrier embryo. RESULT(S): In 9 of 11 patients (82%), translocation breakpoints were successfully identified. In four patients with a term PGD pregnancy established with a balanced/euploid embryo of unknown carrier status, the correct carrier status was retrospectively determined, matching with the cytogenetic karyotype of the resulting newborns. In a prospective PGD cycle undertaken by a patient with a 46,XY,t(7;14)(q22;q24.3) translocation, the four balanced/euploid embryos identified comprised three carriers and one noncarrier. Transfer of the noncarrier embryo resulted in birth of a healthy girl who was subsequently confirmed with a normal 46,XX karyotype. CONCLUSION(S): The combination of mate pair sequencing and PCR breakpoint analysis of balanced reciprocal translocation derivatives is a novel, reliable, and accurate strategy for distinguishing between carrier and noncarrier balanced/euploid embryos. The method has potential application in clinical PGD cycles for patients with reciprocal translocations or other structural rearrangements.
引用
- Wang L, Shen J, Cram DS, et al. Preferential selection and transfer of euploid noncarrier embryos in preimplantation genetic diagnosis cycles for reciprocal translocations. Fertil Steril. 2017. PMID: 28863935. doi:10.1016/j.fertnstert.2017.07.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。